Skip to content

Research on the establishment of a breast cancer diagnosis model based on conventional laboratory indicators and imaging indicators and its clinical application value

Research on the establishment of a breast cancer diagnosis model based on conventional laboratory indicators and imaging indicators and its clinical application value

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118548
Enrollment
Unknown
Registered
2026-02-06
Start date
2026-02-28
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, benign breast diseases

Interventions

Benign breast disease group:NA
Group of healthy people:NA

Sponsors

Harbin Medical University Fourth Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the breast cancer group: (1) Age >= 18 years; 2. The breast cancer group meets the diagnostic criteria for primary breast cancer and is confirmed by pathological examination; 3. Has not received radiotherapy, chemotherapy, or other treatments; 4. All participants in this study are female. Inclusion criteria for the benign breast group: (1) Age >= 18 years; 5. Participants diagnosed with benign breast lesions by pathology; 6. All participants in this study are female. Inclusion criteria for the healthy population group: (1) Age >= 18 years; 7. Women who underwent health check-ups at this hospital during the same period.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for the breast cancer group: (1) Presence of other malignant tumors or gynecological diseases; (2) Women who are pregnant or breastfeeding; (3) Those with severe liver, kidney, heart, etc. diseases. Exclusion criteria for the benign breast group: (1) Research participants who have concurrent malignant tumors or gynecological diseases; (2) Pregnant or breastfeeding women; (3) Those with severe liver, kidney, heart, etc. diseases. Exclusion criteria for the healthy population group: History of malignant tumors.

Design outcomes

Primary

MeasureTime frame
AUC;

Secondary

MeasureTime frame
sensitivity;specificity;negative predictive value (NPV);negative predictive value (NPV);Accuracy;

Countries

China

Contacts

Public ContactJiang Yuehong

Harbin Medical University Fourth Affiliated Hospital

Breast123456@163.com+86 197 1371 5707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026